In recent trading session, scPharmaceuticals Inc (NASDAQ:SCPH) saw 0.54 million shares changing hands at last check today with its beta currently measuring 0.15. Company’s recent per share price level of $2.62 trading at $0.38 or 16.96% at last check today assigns it a market valuation of $131.75M. That most recent trading price of SCPH’s stock is at a discount of -115.65% from its 52-week high price of $5.65 and is indicating a premium of 25.95% from its 52-week low price of $1.94. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.24 million shares which gives us an average trading volume of 452.17K if we extend that period to 3-months.
For scPharmaceuticals Inc (SCPH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
scPharmaceuticals Inc (NASDAQ:SCPH) trade information
Upright in the green today for gaining 16.96%, in the last five days SCPH remained trading in the green while hitting it’s week-highest on Thursday, 05/15/25 when the stock touched $2.62 price level, adding 8.71% to its value on the day. scPharmaceuticals Inc’s shares saw a change of -25.99% in year-to-date performance and have moved 4.38% in past 5-day. scPharmaceuticals Inc (NASDAQ:SCPH) showed a performance of -0.95% in past 30-days. Number of shares sold short was 2.28 million shares which calculate 5.22 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 13 to the stock, which implies a rise of 79.85% to its recent value today. Analysts have been projecting 13 as a low price target for the stock while placing it at a high target of 13. It follows that stock’s current price would drop -396.18% in reaching the projected high whereas dropping to the targeted low would mean a loss of -396.18% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -1.52% during past 5 years.
scPharmaceuticals Inc (NASDAQ:SCPH)’s Major holders
Insiders are in possession of 6.38% of company’s total shares while institution are holding 84.33 percent of that, with stock having share float percentage of 90.08%. Investors also watch the number of corporate investors in a company very closely, which is 84.33% institutions for scPharmaceuticals Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at SCPH for having 5.56 million shares of worth $24.18 million. And as of 2024-06-30, it was holding 14.2608 of the company’s outstanding shares.
The second largest institutional holder is RUBRIC CAPITAL MANAGEMENT LP, which was holding about 3.52 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.042 of outstanding shares, having a total worth of $15.33 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.14 shares of worth $3.05 million or 2.26% of the total outstanding shares. The later fund manager was in possession of 953.85 shares on Mar 31, 2025 , making its stake of worth around $2.56 million in the company or a holder of 1.90% of company’s stock.
